Benzaldoxime
CAS: 932-90-1
Ref. 3D-FB71919
10g | Discontinued | ||
25g | Discontinued | ||
50g | Discontinued | ||
100g | Discontinued | ||
250g | Discontinued |
Product Information
- syn-Benzaldoxime
- Benzaldehyde oxime
- N-hydroxy-1-phenylmethanimine
- Benzaldehido-Oxima
- Benzaldehydoxim
- Benzaloxime
- Benzoxime
- Nsc 68362
- α-Benzaldoxime
- α-Benzyl monoxime
- See more synonyms
Benzaldoxime is a competitive inhibitor of the protease enzyme. It forms covalent adducts with serine, cysteine, and threonine residues in the active site of the protease. The binding of benzaldoxime to serine and cysteine residues can be measured in a kinetic assay by monitoring the release of p-nitroanilide from its covalent adduct with these amino acids. Benzaldoxime has been used as a pharmaceutical preparation for the treatment of myocardial infarcts. It is an anhydrous sodium salt that reacts with trifluoroacetic acid to form a coordination complex that inhibits fatty acid synthesis. This inhibition may be due to its ability to react with hydroxyl groups on fatty acid molecules.